Advertisements


Trillium Therapeutics doses first patient with TTI-622

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Aclaris Therapeutics doses first patient in ATI-502 pilot study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: dealsSource: nytApr 23rd, 2018

Trillium Therapeutics announces "at-the-market" issuance program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Anika Therapeutics announces strong patient response in CINGAL 16-02 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Celyad doses first AML patient at final does level in CYAD-01 THINK trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Trillium Therapeutics completes amendment to SIRPaFc license agreement

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

OncoMed doses first patient in Phase 1b portion of anti-TIGIT clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Asterias doses first patient in first-in-human Phase 1 trial of AST-VAC2 in UK

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Iovance Biotherapeutics doses first patient in Europe for C-144-01 Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 7th, 2018

Trillium Therapeutics appoints Yaping Shou, MD, PhD as Chief Medical Officer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 7th, 2018

Trillium Therapeutics files to sell 2.35M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

BioMarin doses first patient in in a Phase 1/2 study evaluating valoctocogene

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2018

Trillium Therapeutics reports Q1 EPS (65c), consensus (90c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 11th, 2018

Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results

Focusing TTI-621 clinical development on T.....»»

Category: earningsSource: benzingaMay 11th, 2018

Krystal Biotech doses first patient in Phase 1/2 trial of KB103

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2018

MyoKardia doses first patient in PIONEER OLE study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2018

Axsome Therapeutics enrolls first patient in AXS-05 Phase 2 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: dealsSource: nytApr 23rd, 2018

Applied Genetic doses first patient in clinical study of AAV-based gene therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 18th, 2018

Trillium Therapeutics resumed with a Market Perform at Leerink

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2018

Nektar doses first patient in Phase 1/2 study for advanced solid tumors

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 11th, 2018

Trillium Therapeutics provides update on TTI-621, TTI-622 clinical programs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 10th, 2018